This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: treatment

December 2025 Br J Cardiol 2025;32:152–7 doi:10.5837/bjc.2025.053

Using nanotechnology for the diagnosis and treatment of coronary artery disease: a narrative review

Reina Ibrahim,* Lea Nohra,* Waleed Inayat Mohamed, Kristina Nasr, Laurentia Fidella Averina Setia Santoso, Peter Raffoul, Abdallah Alkhaldi

Abstract

Introduction Cardiovascular diseases (CVDs) are responsible for the demise of 17.9 million people yearly, making it the main cause of death in the world.1 According to the American Heart Association’s (AHA) 2022 report on heart disease and stroke statistics, the average yearly indirect and direct expenses of CVD in the US were an estimated $378.0 billion in 2017–2018.2 Early detection of coronary artery disease (CAD) and proper treatment can reduce mortality, and the economic burden it brings along. Although progress has been made in the diagnosis of CAD, it has been limited by the low signal-to-noise ratio of conventional imaging modalit

| Full text

October 2011 Br J Cardiol 2011;18:219–22 doi:10.5837/bjc.2011.002

Patent foramen ovale: diagnosis, indications for closure and complications

Sudhakar George, David Hildick-Smith 

Abstract

(more…)

| Full text

January 2009 Br J Cardiol 2009;16:36-41

Amyloid heart disease

Simon Dubrey

Abstract

(more…)

| Full text

January 2008 Br J Cardiol 2008;15:48-50

Pharmacological secondary prevention in people with peripheral arterial disease compared to thosewith coronary artery disease: a missed opportunity

Simon EJ Janes, Joe West, Brian R Hopkinson, John T Walsh

Abstract

Introduction Patients with peripheral arterial disease (PAD) have a high prevalence of modifiable risk factors for coronary artery disease (CAD).1 Consequently, they represent a suitable target for secondary prevention and there is strong evidence that this is beneficial.2–4 We aimed to establish whether people with PAD who are admitted to hospital receive equal pharmacological secondary prevention to those with CAD. Methods We prospectively recruited patients from 1st March 2003 until 1st June 2003 admitted to a vascular surgery ward (PAD) or cardiology ward (CAD) until discharge. All patients had symptomatic established disease and underw

| Full text

November 2005 Br J Cardiol 2005;12:456-8

How would British stroke physicians diagnose and treat hypoxia in patients with acute stroke?

Christine Roffe, Amit Arora, Peter Crome, Richard Gray

Abstract

No content available

| Full text

September 2003 Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 82–AIC 88

Atrial fibrillation after coronary bypass surgery – pathophysiology, resource utilisation and management strategies

Joseph Alex, Gurpreet S Bhamra, Alex RJ Cale, Steven C Griffin, Michael E Cowen, Levent Guvendik

Abstract

No content available

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now